UP

E-cigarette company warned over marketing practices

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The U.S. Food and Drug Administration warned JUUL Labs over false marketing practices for its tobacco products, accusing the vaping company of modifying the risks especially when outreaching to the youth.

Axar.az reports citing AA that agency said it issued a warning letter to JUUL Labs Inc. ''for marketing unauthorized modified risk tobacco products by engaging in labeling, advertising, and/or other activities directed to consumers, including a presentation given to youth at a school''.

The FDA's investigation of JUUL is the latest in a series of actions it has taken as part of an effort to shed light on the illegal marketing practices of e-cigarette companies and other electronic nicotine delivery systems (ENDS).

The FDA has been under fire recently by parents and health NGOs over its negligence to investigate the recent respiratory illnesses and deaths associated with vaping especially among the youth.

The agency had to launch a wide-ranging investigation after the vaping-related illnesses claimed four lives in the U.S. last week and hundreds of others were reported sick.

As many as 450 people across 33 U.S. states were hospitalized with lung illnesses related to the use of the electronic devices, health officials announced.

Date
2019.09.12 / 18:52
Author
Axar.az
See also

WHO pushes bold reforms, launching 3 by 35 initiative

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Monkeypox case confirmed in Azerbaijan

WHO calls for international support to fund aid in Gaza

30 metapneumovirus cases reported in Kazakhstan

Human metapneumovirus epidemic reported in China

WHO marks 5 years of COVID-19 and ongoing efforts

Expert warns of public health emergency in Delhi

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla